Diabetes Prevention
28
2
2
25
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 28 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
4%
1 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (28)
Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal Triglyceridemia
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
Optimizing Implementation of the Intensive Diabetes Prevention Program
The SCULPT-Job Cohort Study
vDPP Facilitated With Community Care Coordination
ObeSity and Jobs in SoCioeconomically Disadvantaged CommUnities: A Randomized CLinical Precision Public HealTh Intervention --The SCULPT-Job Study
Pilot Study Evaluating the Acceptability and Absorption of the Bioactive Compounds of a Russian Tarragon Nutrasorb Bar
Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 2
A FINEH Protein Trial - Part 1
PERFECT Project - Part 2 - Study 2
PERFECT Project - Part 1 - Study 1
PERFECT Project - Part 1 - Study 3
PERFECT Project - Part 1 - Study 2
PERFECT Project - Part 2 - Study 3
The Reach and Effectiveness of Technology-enhanced Diabetes Prevention Programs
Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)
Parents and Children Together Preventing Diabetes (PACT PD)
Community Health Worker Diabetes Prevention Intervention
Families Defeating Diabetes
Medicaid Incentives for the Prevention of Chronic Diseases: Diabetes Prevention